Meropenem-driven amplification of blaAFM-1 leads to high-level cefiderocol resistance in difficult-to-treat Pseudomonas aeruginosa
Drug Resistance Updates · 2026
DOI: 10.1016/j.drup.2026.101419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2026. Verfasst von Hanxu Hong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 17 Yongwai Zhengjie, Nanchang 330006,…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, beta-Lactamases, Cefiderocol, Gene Amplification. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, Health Commission of Jiangxi Province.
Abstract (Originalsprache)
Cefiderocol (FDC) is a last-resort antibiotic against carbapenem-resistant Pseudomonas aeruginosa, yet mechanisms underlying high-level resistance remain unclear. Here, we report that meropenem exposure induces dynamic tandem amplification of blaAFM-1, leading to markedly increased FDC resistance. This amplification occurs without changes in plasmid copy number and declines without antibiotic pressure, highlighting a clinically relevant pathway of indirect resistance selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 17 Yongwai Zhengjie, Nanchang 330006, China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China; Department II of Respiratory and Critical Care Medicine, Jiangxi Provin…
- Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 17 Yongwai Zhengjie, Nanchang 330006, China; Jiangxi Medical Center for Critical Public Health Events, The…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- Health Commission of Jiangxi Province
Zitieren
APA
Hong, H., Zhang, T., & Liu, Y. (2026). Meropenem-driven amplification of blaAFM-1 leads to high-level cefiderocol resistance in difficult-to-treat Pseudomonas aeruginosa. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101419
Vancouver
Hong H, Zhang T, Liu Y. Meropenem-driven amplification of blaAFM-1 leads to high-level cefiderocol resistance in difficult-to-treat Pseudomonas aeruginosa. Drug Resistance Updates. 2026. doi:10.1016/j.drup.2026.101419
BibTeX
@article{Hong2026,
author = {Hong, Hanxu and Zhang, Ting and Liu, Yang},
title = {Meropenem-driven amplification of blaAFM-1 leads to high-level cefiderocol resistance in difficult-to-treat Pseudomonas aeruginosa},
journal = {Drug Resistance Updates},
year = {2026},
doi = {10.1016/j.drup.2026.101419}
}
EUVIMED